Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Examining the Link Between Trace Elements and Cardiovascular Disease Risk Factors in Young Adults
This study is ongoing, but not recruiting participants.
Sponsored by: National Heart, Lung, and Blood Institute (NHLBI)
Information provided by: National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier: NCT00318734
  Purpose

Cardiovascular disease (CVD) affects millions of people in the United States; each year, more people die from CVD than from any other disease. There are many dietary and lifestyle factors that may increase the risk of developing CVD. Preliminary research has shown that the presence of certain trace elements may be associated with the development of CVD. This study will examine toenail clippings and laboratory data to evaluate the link between trace elements and CVD risk factors in young adults.


Condition
Cardiovascular Diseases
Metabolic Syndrome X
Hypertension
Inflammation
Atherosclerosis

MedlinePlus related topics: High Blood Pressure Metabolic Syndrome
U.S. FDA Resources
Study Type: Observational
Study Design: Natural History, Longitudinal, Defined Population, Prospective Study
Official Title: Trace Elements and CVD Risk Factors Among Young Adults

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Estimated Enrollment: 4362
Study Start Date: May 2006
Detailed Description:

CVD is a disorder that affects the heart's ability to function normally. The most common cause of heart disease is narrowing or blockage of the coronary arteries, which supply blood to the heart. There are many risk factors for CVD, including inflammation, high blood pressure, high cholesterol, and obesity. Small quantities of trace elements, also known as micronutrients, are essential in maintaining a healthy body. Research has shown that some trace elements may be associated with the development of CVD, but more research is needed to confirm this connection. This study will examine concentrations of several trace elements in toenail samples of young adults participating in the Coronary Artery Risk Development in Young Adults (CARDIA) study. The CARDIA study is measuring changes in CVD risk factors in individuals as they age and is identifying lifestyle habits that influence those changes. The purpose of this study is to determine the link between trace elements and CVD risk factors in young adults. The results of this study may help to identify whether dietary, lifestyle, or environmental factors can be modified at a young age to prevent the development of CVD.

This study will examine laboratory and medical history data of participants who are already enrolled in the CARDIA study; there are no additional study visits specifically for this study. Toenail samples collected from participants during their Year 2 CARDIA study visit in the late 1980’s will be examined to determine the presence of selenium, chromium, arsenic, and mercury. Participants’ CARDIA study data will be reviewed and several CVD risk factors will be analyzed, including the thickness of heart arteries; calcium buildup within the arteries; inflammatory markers, such as high sensitivity C-reactive protein and interleukin 6; blood pressure levels; body weight; and levels of cholesterol, fat, and sugar.

  Eligibility

Ages Eligible for Study:   20 Years to 32 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Enrolled in the CARDIA study; this current study will be using existing CARDIA study data and will not be recruiting any new participants
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00318734

Locations
United States, North Carolina
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Sponsors and Collaborators
Investigators
Principal Investigator: Ka He, MD The University of North Carolina, Chapel Hill
  More Information

Study ID Numbers: 1335, R01 HL081572-01A1
Study First Received: April 25, 2006
Last Updated: May 11, 2007
ClinicalTrials.gov Identifier: NCT00318734  
Health Authority: United States: Federal Government

Keywords provided by National Heart, Lung, and Blood Institute (NHLBI):
Blood Pressure, High

Study placed in the following topic categories:
Atherosclerosis
Arterial Occlusive Diseases
Metabolic Syndrome X
Metabolic Diseases
Vascular Diseases
Arteriosclerosis
Inflammation
Hyperinsulinism
Syndrome X
Insulin Resistance
Metabolic disorder
Glucose Metabolism Disorders
Abdominal obesity metabolic syndrome
Hypertension

Additional relevant MeSH terms:
Disease
Pathologic Processes
Syndrome
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 13, 2009